Key facts
- CeQur Simplicity’s last known valuation is $342.4M (Sep 2015).
- It has raised $392.9M; the latest was Later Stage VC ($120.0M) in Jan 2025.
- Notable investors include Vi Partners, Schroders, Woodford Investment Management, Kingdon Capital Management, Endeavour Vision — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for CeQur Simplicity
- ·The full record, as it builds
Funding rounds
No funding rounds for CeQur Simplicity are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CeQur Simplicity
Developer of an insulin patch designed to simplify insulin delivery and improve the lives of diabetes patients. The company's device consists of a simple and discreet wearable insulin delivery holder that delivers both basal and bolus insulin, enabling patients to easily experience the benefits of intensive insulin therapy while remaining free from the burdens of daily insulin injections.
- Sector
- Healthcare
- HQ
- Luzern, Switzerland
- Founded
- 2008
- Employees
- 135
- Website
- myceqursimplicity.com/
- Ownership
- Privately Held (backing)
CeQur Simplicity doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CeQur Simplicity shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CeQur Simplicity in its N-PORT filings yet. We sweep new filings monthly.